Andreas Kuhn

Andreas Kuhn

Company: BioNTech SE

Job title: SVP - RNA Biochemistry & Manufacturing

Seminars:

Panel Discussion – Benchmarking Regulatory Harmonization for State-of-the-Art Analytical Methods, Qualification, and Validation 9:40 am

With the expansion of mRNA-therapeutic applications at an accelerated pace, there is now a greater necessity to characterize mRNA to better understand their mechanisms of action and the performance systems. Novel analytical approaches, specifically within production, purification and high throughput automation needs to be developed to address design, test and analyse such systems. Validation of…Read more

day: Day Two

Analytical Characterization of mRNA-Based Therapeutics & Vaccines 8:30 am

As a still new technology for therapeutics and vaccines, the critical quality attributes for mRNA need further refinement For this, it is important to characterize mRNA as good as possible and correlate this to its functionality Here, a set of assays for the characterization of mRNA will be presentedRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.